OBJECTIVE: This study employed psychometric tools to assess the impact of factors such as age, symptom location, and duration on the improvement in burning mouth syndrome (BMS). MATERIALS AND METHODS: A total of 86 women with BMS were divided into 4 groups: laser plus clonazepam (n = 24), sham laser placebo (n = 20), laser only (n = 22), and clonazepam only (n = 20). Symptom severity was measured using the Visual Analog Scale (VAS), while depression and anxiety were evaluated using the Hospital Anxiety and Depression Scale (HADS). Stress levels were assessed using the Perceived Stress Scale (PSS) and somnolence with the Epworth Somnolence Scale (ESS). Questionnaires were completed at baseline, 1 month post-treatment, and at 3 months of follow-up. RESULTS: Symptom intensity significantly decreased from baseline to study end (P < .001), with minor increases during follow-up. Stress levels also significantly declined (P = .016), while anxiety, depression, and somnolence showed no significant changes (P > .05). Symptom intensity correlated with age (P < .001), and initial anxiety correlated with disease duration (P = .027). CONCLUSION: Age, disease duration, and symptom location did not significantly influence symptom improvement, psychological state, or somnolence. Further multidisciplinary research is needed.
No clinical trial protocols linked to this paper
Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.PICO Elements
No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.
Paper Details
MeSH Terms
Associated Data
No associated datasets or code repositories found for this paper.
Related Papers
Related paper suggestions will be available in future updates.